A stealthy conflict rages across the sensitive net of human connection: cholangiocarcinoma, or bile duct cancers, silently destroys the brilliant connections of our bodies.
Provider and patient perspectives on why patient education about FGFRi treatment-associated adverse events and how to manage them are is essential in helping patients maintain a good quality of life and stay on treatment.